Lee-Ann Farrell

Patients

In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Lee-Ann Farrell, Head of National Programmes at Johnson & Johnson.

News

Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.